In-vivo effect of nicotine on cytokine production by human non-adherent mononuclear cells

European Journal of Gastroenterology and Hepatology

Volumn 8, Issue 10, 1996, Pages 1017-1020

  Madretsma, Stanley ^a,b   Wolters, Leonieke M M ^a   Van Dijk, Jeanette P M ^b   Tak, Corné J A M ^a   Feyerabend, Colin ^c   Wilson, J H Paul ^b   Zijlstra, Freek J ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c New Cross Hospital ^*  (United Kingdom)

Author keywords

Cytokines; Human mononuclear cells; Nicotine

Indexed keywords

COTININE; INTERLEUKIN 10; INTERLEUKIN 2; NICOTINE; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD PRESSURE; CROHN DISEASE; HEART RATE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; TRANSDERMAL DRUG ADMINISTRATION; ULCERATIVE COLITIS;

EID: 0029908403     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199610000-00016     Document Type: Article

References (20)

1. Mullin GE, Lazenby AJ, Harris, Bayless TM, James SP: Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. Gastroenterology 1992, 102:1620-1627.
2. Breese E, Braegger CP, Corrigan CJ, Walker-Smith JA, MacDonald TT: Interleukin-2- and interferon-γ-secreting T cells in normal and diseased human mucosa. Immunology 1993, 78:127-131.
3. Mullin GE, Vezza FR, Sampat A, Maycon Z, Kalz R, Eisenstein E, et al.: Abnormal IL-10 mRNA production in the intestinal mucosal lesions of inflammatory bowel disease. Gastroenterology 1993, 104:A751.
4. Harries AD, Baird A, Rhodes J: Non-smoking: a feature of ulcerative colitis. BMJ 1982, 284:706.
5. Logan RFA, Edmond M, Sommerville KW, Langman MJ: Smoking and ulcerative colitis. BMJ 1984, 288:751-753.
6. Cottone M, Rosselli M, Orlando A, Oliva L, Puleo A, Cappello M, et al.: Smoking habits and recurrence in Crohn's Disease. Gastroenterology 1994, 106:643-648.
7. Srivastava ED, Russel MAH, Feyerabend C, Williams GT, Matterson JG, Rhodes J: Transdermal nicotine in active ulcerative colitis. Eur J Gastroenterol 1991, 3:815-818.
8. Pullan RD, Rhodes J, Ganesh S, Mani V, Morris JS, Williams GT, et al.: Transdermal nicotine for ulcerative colitis. N Engl J Med 1994, 330:811-815.
9. Srivastava ED, Barton J, O'Mahoney S, Phillips D, Williams G, Matthews N: Smoking, humoral immunity and ulcerative colitis. Gut 1991, 32:1016-1019.
10. Barton JR, Raid MA, Gaze MN, Maran AG, Ferguson A: Mucosal immuno-deficiency in smokers and in patients with epithelial head and neck tumours. Gut 1990, 31:378-382.
11. Andersen P, Pedersen OF, Bach B, Bonde GJ: Serum antibodies and immunoglobulins in smokers and nonsmokers. Clin Exp Immunol 1982, 47:467-473.
12. Ferson M, Edwards A, Lind A, Milton GW, Hersey P: Low natural killer-cell activity and immunoglobulin levels associated with smoking in human subjects. Int J Cancer 1979, 23:603-609.
13. Mili F, Flanders WD, Boring JR, Annest JL, Destefano F: The associations of race, cigarette smoking, and smoking cessation to measures of the immune system in middle-aged men. Clin Immunol Immunopathol 1991, 59:187-200.
14. Miller LG, Golstein G, Murphy M, Ginns LC: Reversible alterations in immunoregulatory T cells in smoking: analysis by monoclonal antibodies and flow cytometry. Chest 1982, 82:526-529.
15. Boyum A: Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968, 21(suppl. 97):77-89.
16. Rutgeers P, D'Haens G, Hiele M, Geboes K, Vantrappen G: Appendectomy protects against ulcerative colitis. Gastroenterology 1994, 106:1251-1253.
17. Madretsma GS, Van Dijk APM, Tak CJAM, Donze GJ, Wilson JHP, Zijlstra FJ: Nicotine in vitro inhibits the production of IL-2 and TNFα by peripheral blood and intestinal mononuclear cells. Gastroenterology 1995, 108:A867.
18. Grabczewska E, Laskowska-Bozek H, Maslinski W, Ryzewski J: Cholinergic muscarinic and nicotinic binding by human lymphocytes: differences between peripheral blood cells and cultivated cell lines. Int J Tiss React 1990, 12(5):281-289.
19. Rousset F, Garcia E, Defrance T, Peronne C, Vezzio N, Hsu DH, et al: Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 1992, 89:1890-1893.
20. Ishida H, Hastings R, Thompson-Snipes L, Howard M: Modified immunological status of anti-IL-10 treated mice. Cell Immunol 1993, 148:371-384.